Evidence for the Existence of a CXCL17 Receptor Distinct from GPR35
Author:
Publisher
The American Association of Immunologists
Subject
Immunology,Immunology and Allergy
Reference46 articles.
1. The Chemokine Superfamily Revisited
2. International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors
3. Clinical use of CCR5 inhibitors in HIV and beyond.;Gilliam;J. Transl. Med.,2011
4. A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor
5. Optimizing stem cell collection through CXCR4 antagonists.;Mahaseth;Front. Biosci. (Schol. Ed.),2012
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Is myeloid-derived growth factor a ligand of the sphingosine-1-phosphate receptor 2?;Biochemical and Biophysical Research Communications;2024-04
2. CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans;Science Signaling;2024-03-19
3. Is myeloid-derived growth factor a ligand of the sphingosine-1-phosphate receptor 2?;2024-02-24
4. CXCL17 is a proinflammatory chemokine and promotes neutrophil trafficking;Journal of Leukocyte Biology;2024-01-31
5. The origin, evolution, and molecular diversity of the chemokine system;Life Science Alliance;2024-01-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3